Anixa Biosciences is trading 5.3% up at $3.71 despite a lack of fresh company-specific news, regulatory updates, or analyst calls hitting the wires.
- The move extends a choppy but overall positive trend observed over the past week.
- Market observers suggest the price action may reflect typical low-float volatility, speculative trading, or investor positioning rather than a clearly identified fundamental driver.